胰腺癌-话题@MedSci

#胰腺癌#

94篇内容 | 7468人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=809573, encodeId=5e078095e384, content=<a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a><a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a><a href='/topic/show?id=48b983982ae' target=_blank style='color:#2F92EE;'>#胰腺癌风险#</a>买际上体重快速下降，不是胰腺癌也可能是其它肿瘤, objectTitle=JAMA Oncol：15万人随访30年发现，糖尿病患者体重减轻，与胰腺癌风险增至2.8-6倍有关, objectType=article, longId=199570, objectId=6a291995e0df, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200813/b06328be24f74a77810ea8a878b1c4b9.jpg, objectUrl=/article/show_article.do?id=6a291995e0df, replyNumber=0, likeNumber=249, createdTime=2020-08-17, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a291995e0df, moduleTitle=JAMA Oncol：15万人随访30年发现，糖尿病患者体重减轻，与胰腺癌风险增至2.8-6倍有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a291995e0df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=808690, encodeId=b58c808690cc, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>多学科共识, objectTitle=中国胰腺癌多学科综合治疗模式专家共识（2020版）, objectType=guider, longId=12162, objectId=9c0351c0019523d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=9c0351c0019523d5, replyNumber=0, likeNumber=142, createdTime=2020-08-14, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c0351c0019523d5, moduleTitle=中国胰腺癌多学科综合治疗模式专家共识（2020版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=9c0351c0019523d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=805130, encodeId=b2bc80513031, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>似乎氯沙坦与放疗可以协同, objectTitle=前所未有！新方案让晚期胰腺癌患者“重获新生”, objectType=article, longId=168104, objectId=fa361681046d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201906/20190611092820776.jpg, objectUrl=/article/show_article.do?id=fa361681046d, replyNumber=0, likeNumber=184, createdTime=2020-07-30, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa361681046d, moduleTitle=前所未有！新方案让晚期胰腺癌患者“重获新生”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa361681046d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=805129, encodeId=c8fc80512974, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>氯沙坦有效，很难解释, objectTitle=前所未有！新方案让晚期胰腺癌患者“重获新生”, objectType=article, longId=168104, objectId=fa361681046d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201906/20190611092820776.jpg, objectUrl=/article/show_article.do?id=fa361681046d, replyNumber=0, likeNumber=160, createdTime=2020-07-30, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa361681046d, moduleTitle=前所未有！新方案让晚期胰腺癌患者“重获新生”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa361681046d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=805128, encodeId=fdef8051280b, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>免疫治疗获益仍然十分有限, objectTitle=Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破, objectType=article, longId=194893, objectId=9c8d19489351, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200527/7576d3a88b084613bb88dcf01c39d356.jpg, objectUrl=/article/show_article.do?id=9c8d19489351, replyNumber=0, likeNumber=203, createdTime=2020-07-30, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c8d19489351, moduleTitle=Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c8d19489351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=805127, encodeId=c80880512ee0, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>羟氯喹增敏，氯沙坦增效, objectTitle=Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗, objectType=article, longId=193051, objectId=fe3d193051d9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020426/1587888865310_1968710.png, objectUrl=/article/show_article.do?id=fe3d193051d9, replyNumber=0, likeNumber=222, createdTime=2020-07-30, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3d193051d9, moduleTitle=Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3d193051d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=803815, encodeId=55cc80381567, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>这个点很少关注到, objectTitle=2020 国际共识指南：慢性胰腺炎患者胰腺癌监测, objectType=guider, longId=12018, objectId=0fde51c00193e95d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=0fde51c00193e95d, replyNumber=0, likeNumber=192, createdTime=2020-07-22, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fde51c00193e95d, moduleTitle=2020 国际共识指南：慢性胰腺炎患者胰腺癌监测, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=0fde51c00193e95d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601621, encodeId=87b5601621e7, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>这个病例值得深入的看一看。, objectTitle=病例丨胰腺癌治疗策略分享, objectType=article, longId=194286, objectId=3baf194286a1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020517/1589679823127_2202541.png, objectUrl=/article/show_article.do?id=3baf194286a1, replyNumber=0, likeNumber=209, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3baf194286a1, moduleTitle=病例丨胰腺癌治疗策略分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3baf194286a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601608, encodeId=ce64601608f2, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>这仅仅是转化研究，目前还不能得出的结论琳琳张，还有很长的距离。, objectTitle= J Control Release：研究发现治疗胰腺癌的新疗法, objectType=article, longId=194786, objectId=02b7194e8606, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/112.jpg, objectUrl=/article/show_article.do?id=02b7194e8606, replyNumber=0, likeNumber=203, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02b7194e8606, moduleTitle= J Control Release：研究发现治疗胰腺癌的新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02b7194e8606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601606, encodeId=de09601606f7, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>胰腺癌目前主要的治疗方法是综合治疗，密集化疗或者加免疫治疗，再加上其他一些综合治疗手段整体效果比以前有很大的进步。, objectTitle=, objectType=topic, longId=83976, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=126, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601604, encodeId=99d5601604f7, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>在新辅助治疗中，是不是也需要增加免疫治疗？, objectTitle=ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？, objectType=article, longId=195015, objectId=16171950156b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200530/6294043042bc43b0bfcd1d3fe2c12a9a.jpg, objectUrl=/article/show_article.do?id=16171950156b, replyNumber=0, likeNumber=192, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16171950156b, moduleTitle=ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16171950156b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601603, encodeId=9e81601603bf, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>多联治疗，暂时效果不错, objectTitle=Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破, objectType=article, longId=194893, objectId=9c8d19489351, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200527/7576d3a88b084613bb88dcf01c39d356.jpg, objectUrl=/article/show_article.do?id=9c8d19489351, replyNumber=0, likeNumber=214, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c8d19489351, moduleTitle=Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c8d19489351)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=601599, encodeId=c21d60159978, content=<a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>有点病急乱投医感觉，什么方法都试试, objectTitle=胰腺癌最新疗法：细胞疗法、肿瘤治疗电场、大麻素均上榜, objectType=article, longId=147957, objectId=57e214e95730, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201808/20180831163018191.jpg, objectUrl=/article/show_article.do?id=57e214e95730, replyNumber=0, likeNumber=135, createdTime=2020-06-06, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57e214e95730, moduleTitle=胰腺癌最新疗法：细胞疗法、肿瘤治疗电场、大麻素均上榜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e214e95730)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

何时让癌王不再是癌王？！

2020-05-29

lovetcm (审核中...)

前往app查看评论内容

#糖尿病##胰腺癌##胰腺癌风险#买际上体重快速下降，不是胰腺癌也可能是其它肿瘤

JAMA Oncol：15万人随访30年发现，糖尿病患者体重减轻，与胰腺癌风险增至2.8-6倍有关

2020-08-17

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#多学科共识

中国胰腺癌多学科综合治疗模式专家共识（2020版）

2020-08-14

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#似乎氯沙坦与放疗可以协同

前所未有！新方案让晚期胰腺癌患者“重获新生”

2020-07-30

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#氯沙坦有效，很难解释

前所未有！新方案让晚期胰腺癌患者“重获新生”

2020-07-30

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#免疫治疗获益仍然十分有限

Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破

2020-07-30

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#羟氯喹增敏，氯沙坦增效

Nature：新突破：胰腺癌治疗新方法——羟化氯喹+化疗

2020-07-30

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#这个点很少关注到

2020 国际共识指南：慢性胰腺炎患者胰腺癌监测

2020-07-22

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#这个病例值得深入的看一看。

病例丨胰腺癌治疗策略分享

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#这仅仅是转化研究，目前还不能得出的结论琳琳张，还有很长的距离。

J Control Release：研究发现治疗胰腺癌的新疗法

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#胰腺癌目前主要的治疗方法是综合治疗，密集化疗或者加免疫治疗，再加上其他一些综合治疗手段整体效果比以前有很大的进步。

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#在新辅助治疗中，是不是也需要增加免疫治疗？

ASCO 2020：新辅助治疗是否改善可切除胰腺癌患者预后？

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#多联治疗，暂时效果不错

Nat Med：CXCR4拮抗剂+PD-1抑制剂+化疗三联疗法治疗胰腺癌获突破

2020-06-06

lovetcm (审核中...)

前往app查看评论内容

#胰腺癌#有点病急乱投医感觉，什么方法都试试

胰腺癌最新疗法：细胞疗法、肿瘤治疗电场、大麻素均上榜

2020-06-06

科室
- - 订阅+
  - 更多科室
工具
服务